Implementing Zero Suicide in Health Systems is sponsored by Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services. Implements the comprehensive Zero Suicide intervention and prevention model for adults within health systems. Requires application of seven framework elements: Lead, Train, Identify, Engage, Treat, Transition, and Improve.

Utah Primary Care Grant Program is a grant from the Utah Department of Health and Human Services – Office of Primary Care and Rural Health that funds organizations providing primary healthcare to medically underserved and low-income populations across Utah. The program increases access to ambulatory primary care services for low-wage workers, children, the elderly, migrant farmworkers, and the uninsured or underinsured. Eligible applicants include private non-profit and public organizations delivering primary healthcare in Utah. The 2026 application cycle opened March 9 and closed March 31, 2026, with an application orientation held on March 17.

Utah Primary Care Grant Program is a grant from the Utah Department of Health and Human Services Office of Primary Care and Rural Health that funds organizations providing primary healthcare to medically underserved populations in Utah. The program supports ambulatory primary care services for low-income, uninsured, and underinsured individuals — including workers with low wages, families without health insurance ineligible for Medicaid or CHIP, and patients needing services not covered by existing insurance. Objectives include improving health outcomes, ensuring care continuity, and expanding organizational capacity to serve target populations. Eligible applicants are private nonprofit and public organizations in Utah providing primary healthcare. The 2026 application cycle closed March 31, 2026.

NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) is sponsored by National Institutes of Health (NIH). This Parent Notice of Funding Opportunity supports exploratory and developmental research projects that propose at least one clinical trial. These projects involve early and conceptual stages of research that may carry considerable risk but have the potential for significant impact on biomedical, behavioral, or clinical research, including the development of novel techniques, agents, methodologies, models, or applications.